Zhuojing Chen, MD; Yuwei Lin, MPH; Yao Qin, MD; et al.
free access
JAMA Dermatol. 2023;159(10):1059-1067. doi:10.1001/jamadermatol.2023.2634
This retrospective cohort study of patients with mycosis fungoides evaluates prognostic factors and survival outcomes among a cohort in China during 12 years.
Shayan Cheraghlou, MD; Nicole A. Doudican, PhD; Maressa C. Criscito, MD; et al.
free access
JAMA Dermatol. 2023;159(10):1068-1075. doi:10.1001/jamadermatol.2023.2822
This cohort study of adults with Merkel cell carcinoma evaluates the association of Mohs micrographic surgery vs wide local excision with overall survival.
Russell G. Witt, MD, MAS; Samuel H. Cass, MD; Tiffaney Tran, BS; et al.
free access
has audio
JAMA Dermatol. 2023;159(10):1076-1084. doi:10.1001/jamadermatol.2023.2955
This case-control study compares differences in the fecal microbiota鈥攊ncluding overall diversity, composition, and putative function鈥攂etween control participants and patients with melanoma and between patients with early- and late-stage melanoma.
-
Podcast:
Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma
Zelma C. Chiesa Fuxench, MD, MSCE; Joy Wan, MD, MSCE; Sonia Wang, BS; et al.
free access
JAMA Dermatol. 2023;159(10):1085-1092. doi:10.1001/jamadermatol.2023.2875
This cohort study examines the association between atopic dermatitis and inflammatory bowel disease in children and adults.
Yaxin Du, BM; Wenjie Wu, BM; Mei Chen, MD; et al.
free access
JAMA Dermatol. 2023;159(10):1093-1101. doi:10.1001/jamadermatol.2023.3003
This systematic review and meta-analysis examines the association between cutaneous immune-related adverse events and cancer prognosis among patients receiving immune checkpoint inhibitor treatment.
Ali Alsouhibani, PT, PhD; Patrick Speck, MD; Emily F. Cole, MD, MPH; et al.
free access
JAMA Dermatol. 2023;159(10):1102-1111. doi:10.1001/jamadermatol.2023.3243
This cross-sectional study examines the use of quantitative sensory testing to characterize somatosensory profiles among patients with hidradenitis suppurativa at clinically affected and nonaffected sites.